Not applicableStudy completedNCT00712556What this trial is testingPET Study in Patients With Non-Hodgkin LymphomaWho this might be right forLymphoma Vanderbilt-Ingram Cancer Center 55
Testing effectiveness (Phase 2)Ended earlyNCT00617929What this trial is testingAntithymocyte Globulin, Clofarabine, and Rituximab in Treating Patients After an Unsuccessful Stem Cell TransplantWho this might be right forCancer Masonic Cancer Center, University of Minnesota 12
Early research (Phase 1)Study completedNCT00891137What this trial is testingSafety Study of Human Myeloid Progenitor Cells (CLT-008) After Cord Blood Transplant for Hematologic MalignancyWho this might be right forLeukemiaLymphomaMultiple Myeloma+2 more Cellerant Therapeutics 30
Not applicableStudy completedNCT00274794What this trial is testingVP and G-CSF With or Without Rituximab in Autologous Peripheral Stem Cell Transplant For NHLWho this might be right forLymphoma The Cleveland Clinic 55
Early research (Phase 1)Study completedNCT00003970What this trial is testingGenetic Testing Plus Irinotecan in Treating Patients With Solid Tumors or LymphomaWho this might be right forAIDS-related Peripheral/Systemic LymphomaAIDS-related Primary CNS LymphomaAnaplastic Large Cell Lymphoma+56 more National Cancer Institute (NCI) 60
Early research (Phase 1)Active Not RecruitingNCT02153580What this trial is testingCellular Immunotherapy Following Chemotherapy in Treating Patients With Recurrent Non-Hodgkin Lymphomas, Chronic Lymphocytic Leukemia, or B-Cell Prolymphocytic LeukemiaWho this might be right forB-Cell Lymphoma, Unclassifiable, With Features Intermediate Between Diffuse Large B-Cell Lymphoma and Classic Hodgkin LymphomaB-Cell Prolymphocytic LeukemiaHigh Grade B-Cell Lymphoma, Not Otherwise Specified+10 more City of Hope Medical Center
Testing effectiveness (Phase 2)Ended earlyNCT01998035What this trial is testingRomidepsin Plus Oral 5-Azacitidine in Relapsed/Refractory Lymphoid MalignanciesWho this might be right forLymphoid MalignanciesLymphomaHodgkin Lymphoma+1 more Columbia University 58
Testing effectiveness (Phase 2)Study completedNCT00002725What this trial is testingBryostatin-1 in Treating Patients With Recurrent Non-Hodgkin's LymphomaWho this might be right forLymphoma National Cancer Institute (NCI) 35
Not applicableUnknownNCT00295997What this trial is testingDonor Stem Cell Transplant in Treating Patients With Hematologic Cancer, Metastatic Kidney Cancer, or Aplastic AnemiaWho this might be right forChronic Myeloproliferative DisordersKidney CancerLeukemia+4 more University of California, San Francisco 35
Early research (Phase 1)Study completedNCT00002625What this trial is testingTopotecan and Radiation Therapy in Treating Patients With Solid Tumors or LymphomaWho this might be right forEsophageal CancerLung CancerLymphoma National Cancer Institute (NCI) 5
Early research (Phase 1)Study completedNCT00003993What this trial is testingBryostatin 1 and Interleukin-2 in Treating Patients With Refractory Solid Tumors or LymphomaWho this might be right forLymphomaSmall Intestine CancerUnspecified Adult Solid Tumor, Protocol Specific National Institute on Aging (NIA) 24
Testing effectiveness (Phase 2)Looking for participantsNCT05672251What this trial is testingLoncastuximab Tesirine and Mosunetuzumab for the Treatment of Relapsed or Refractory Diffuse Large B-Cell LymphomaWho this might be right forRecurrent Diffuse Large B-Cell LymphomaRecurrent Grade 3b Follicular LymphomaRecurrent High Grade B-Cell Lymphoma+9 more City of Hope Medical Center 36
Early research (Phase 1)Ended earlyNCT00004239What this trial is testing506U78 in Treating Patients With Hematologic Cancer and Kidney or Liver ImpairmentWho this might be right forChronic Myeloproliferative DisordersLeukemiaLymphoma+2 more Alliance for Clinical Trials in Oncology 10
Testing effectiveness (Phase 2)Study completedNCT00078858What this trial is testingMycophenolate Mofetil and Cyclosporine in Reducing Graft-Versus-Host Disease in Patients With Hematologic Malignancies or Metastatic Kidney Cancer Undergoing Donor Stem Cell TransplantWho this might be right forAccelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in Remission+132 more Fred Hutchinson Cancer Center 37
Testing effectiveness (Phase 2)Study completedNCT00002908What this trial is testingBryostatin 1 in Treating Patients With Relapsed Non-Hodgkin's Lymphoma or Chronic Lymphocytic LeukemiaWho this might be right forLeukemiaLymphoma Barbara Ann Karmanos Cancer Institute
Testing effectiveness (Phase 2)Ended earlyNCT00089076What this trial is testingMDX-010 in Treating Patients With Recurrent or Refractory LymphomaWho this might be right forAdult Grade III Lymphomatoid GranulomatosisB-cell Chronic Lymphocytic LeukemiaCutaneous B-cell Non-Hodgkin Lymphoma+20 more National Cancer Institute (NCI) 18
Early research (Phase 1)Study completedNCT00293345What this trial is testing3-AP and Gemcitabine in Treating Patients With Advanced Solid Tumors or LymphomaWho this might be right forAnaplastic Large Cell LymphomaAngioimmunoblastic T-cell LymphomaExtranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue+56 more National Cancer Institute (NCI) 30
Testing effectiveness (Phase 2)UnknownNCT02981745What this trial is testingStudy of Safety,Efficacy and Pharmacokinetics of CT-1530 in Patients With Relapsed or Refractory B Cell Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia, and Waldenstrom's MacroglobulinemiaWho this might be right forRelapsed or Refractory B Cell Non-Hodgkin LymphomaChronic Lymphocytic LeukemiaWaldenstrom's Macroglobulinemia+3 more Centaurus Biopharma Co., Ltd. 200
Testing effectiveness (Phase 2)Study completedNCT00003396What this trial is testingPeripheral Stem Cell Transplantation in Treating Patients With Hematologic CancerWho this might be right forLeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm+1 more University of Maryland, Baltimore 42
Testing effectiveness (Phase 2)Study completedNCT00436618What this trial is testingEverolimus in Treating Patients With Lymphoma That Has Relapsed or Not Responded to Previous TreatmentWho this might be right forLeukemiaLymphomaLymphoproliferative Disorder Mayo Clinic 277